Barriers and facilitators to pharmacotherapy for alcohol use disorders in primary care: results of a qualitative study in 4 va primary care clinics

Background In the context of routine population-based alcohol screening to identify primary care (PC) patients who might benefit from brief intervention, many patients identified will have alcohol use disorders (AUD) [1] and will likely require more intensive treatments. FDA approved medications are recommended to treat AUD [2] and could be offered in PC. Currently, use of AUD medications is extremely rare. [3] This qualitative study sought to understand barriers and facilitators to prescribing AUD medications in PC.